Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor (EGFR) is a distinct subgroup of NSCLCs that is particularly responsive to EGFR tyrosine-kinase inhibitors (TKIs). A weighted pooled analysis of available studies was performed to evaluate clinical outcome in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Paz-Ares, Luis, Soulières, Denis, Melezínek, Ivan, Moecks, Joachim, Keil, Lorenz, Mok, Tony, Rosell, Rafael, Klughammer, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837609/
https://www.ncbi.nlm.nih.gov/pubmed/20015198
http://dx.doi.org/10.1111/j.1582-4934.2009.00991.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837609/
https://www.ncbi.nlm.nih.gov/pubmed/20015198
http://dx.doi.org/10.1111/j.1582-4934.2009.00991.x

Ejemplares similares